Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt

By Yahoo! Finance   |   11 months ago
Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt

Howard Marks emphasizes that investors should worry more about the risk of permanent loss than share price volatility. Assessing a company's debt is crucial as it can lead to financial ruin if not managed well. Abbott Laboratories (NYSE:ABT) has a manageable debt of $15.

Read More

Did you find this insightful?